153 related articles for article (PubMed ID: 26456186)
21. Hesperetin inhibits KSHV reactivation and is reversed by HIF1α overexpression.
Long WY; Zhao GH; Wu Y
J Gen Virol; 2021 Nov; 102(11):. PubMed ID: 34747688
[TBL] [Abstract][Full Text] [Related]
22. Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency.
Li X; Chen S; Feng J; Deng H; Sun R
J Virol; 2010 Sep; 84(17):8945-8. PubMed ID: 20573831
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency.
Cai Q; Verma SC; Choi JY; Ma M; Robertson ES
J Virol; 2010 Nov; 84(21):11134-44. PubMed ID: 20719954
[TBL] [Abstract][Full Text] [Related]
24. Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus.
Chandriani S; Ganem D
J Virol; 2010 Jun; 84(11):5565-73. PubMed ID: 20219929
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
Cathomas G
Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
[TBL] [Abstract][Full Text] [Related]
26. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
27. Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma.
Klass CM; Offermann MK
Curr Opin Oncol; 2005 Sep; 17(5):447-55. PubMed ID: 16093794
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapy.
Andrei G; Snoeck R
Curr Opin Infect Dis; 2015 Dec; 28(6):611-24. PubMed ID: 26524334
[TBL] [Abstract][Full Text] [Related]
29. Posttranscriptional gene regulation in Kaposi's sarcoma-associated herpesvirus.
Conrad NK
Adv Appl Microbiol; 2009; 68():241-61. PubMed ID: 19426857
[TBL] [Abstract][Full Text] [Related]
30. Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus.
Brown HJ; McBride WH; Zack JA; Sun R
Antivir Ther; 2005; 10(6):745-51. PubMed ID: 16218174
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
Ramalingam D; Happel C; Ziegelbauer JM
J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
[TBL] [Abstract][Full Text] [Related]
32. Activation of cellular metabolism during latent Kaposi's Sarcoma herpesvirus infection.
Lagunoff M
Curr Opin Virol; 2016 Aug; 19():45-9. PubMed ID: 27434732
[TBL] [Abstract][Full Text] [Related]
33. KSHV targeted therapy: an update on inhibitors of viral lytic replication.
Coen N; Duraffour S; Snoeck R; Andrei G
Viruses; 2014 Nov; 6(11):4731-59. PubMed ID: 25421895
[TBL] [Abstract][Full Text] [Related]
34. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein.
Lukac DM; Renne R; Kirshner JR; Ganem D
Virology; 1998 Dec; 252(2):304-12. PubMed ID: 9878608
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
36. KSHV requires vCyclin to overcome replicative senescence in primary human lymphatic endothelial cells.
DiMaio TA; Vogt DT; Lagunoff M
PLoS Pathog; 2020 Jun; 16(6):e1008634. PubMed ID: 32555637
[TBL] [Abstract][Full Text] [Related]
37. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
[TBL] [Abstract][Full Text] [Related]
38. Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia.
Nicholas J
Front Biosci; 2007 Jan; 12():265-81. PubMed ID: 17127298
[TBL] [Abstract][Full Text] [Related]
39. Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.
Lu M; Suen J; Frias C; Pfeiffer R; Tsai MH; Chuang E; Zeichner SL
J Virol; 2004 Dec; 78(24):13637-52. PubMed ID: 15564474
[TBL] [Abstract][Full Text] [Related]
40. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
Lan K; Kuppers DA; Robertson ES
J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
